Review · Partner

Oak review

GLP-1 telehealth · Prices read September 2026

Our verdict

Oak prices compounded semaglutide from $119 a month and tirzepatide from $185, and both figures are the monthly rate on a 12-month plan. Shorter plans are sold, and their prices appear only at checkout.

One month, no commitment

No 1-month price

No price for one month with no commitment appears on their public pages. Every figure they do publish is below.

Real month to month
None confirmed
No one-month price on their public pages.
They advertise
$119/mo
12-month plan
Our finding
$119 needs twelve months
The whole ladder, with the working, is below.
Our relationship
Partner
We earn a commission if you start care through our link.
See plans at Oak →

Price read from Oak's own page

Partner link. We earn a commission if you start care through it, at no extra cost to you. Who pays us.

Compare every priced provider →

The short version

In its favor

  • Clean FDA warning-letter record
  • Prescribers licensed in your state

Against it

  • No single-month price published
  • Consultation fee disclosed, never priced
  • No pharmacy named
  • No support hours published

What it is

Oak is a telehealth brand at Oak's site selling weight-loss, erectile-dysfunction, hair and longevity treatments. For weight loss it lists compounded semaglutide and tirzepatide injections, branded GLP-1 injector pens and oral Wegovy tablets. There's no video visit by default: you answer an online questionnaire, a US-licensed provider reviews it and prescribes only when appropriate, and the medication ships from a licensed US pharmacy. Treatment follows the usual GLP-1 course. Oak's semaglutide page says it's generally considered for adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes. You start on a low dose and step up about every four weeks as tolerated, and the provider checks in, adjusts the dose and helps with side effects, with messaging to the care team open in between. The drug pages print the side-effect and warning information in full, including the pancreatitis and gallbladder warnings and the advice not to combine GLP-1 medications.

The company's name depends on which line you read. The footer says Oak Longevity Holdings Corp. The terms of use open with “Leaf Longevity Holdings Corp. DBA Oak Longevity”, refer elsewhere to Oak Longevity Corp, and carry a second set of terms on the same page issued by Oaklovesyou LLC. Oak calls itself a “tele-health facilitator” that contracts with physicians and pharmacies, and names neither the medical group nor any pharmacy.

Oak does make a clear licensure promise: its home page says its providers are “US licensed providers” in “every state we ship to”, and elsewhere “Licensed in all 50 states”. Which states it ships to isn't listed. The site carries a LegitScript certification badge.

What it actually costs

Oak prices by drug
DrugMonth to monthLowest rate on a longer plan
Compounded semaglutideNot sold alone$119 /mo, 12 months
Compounded tirzepatideNot sold alone$185 /mo, 12 months
Brand semaglutideNot pricedNone listed

Compounded semaglutide is $119 a month and tirzepatide $185, and both are printed as “Per month, 12-month plan”. Those are the only GLP-1 prices on Oak's drug pages. Shorter plans exist, but they're priced only at checkout, so the cost of a single month can't be known before you start.

How the 12-month plan is billed isn't stated. If it's charged at once, that's $1,428 for semaglutide and $2,220 for tirzepatide, which is simple multiplication and not a figure Oak prints. The terms describe subscriptions that renew and charge the card on file for each refill until you cancel.

The price can move with the dose. The terms say “Your Subscription fee may change from time to time based on changes in dosage, prescription or form of product,” and no dose table is published.

There's a fee the marketing doesn't mention. The terms say “patients are charged a membership fee for a Provider consult (either asynchronous or synchronous)” and never say how much it is, while the home page promises “No hidden fees”. The site-wide banner's “from $89/mo” appears on no drug page. Brand Wegovy is “Quoted at checkout”.

Once approved, you're committed to that shipment. The terms say that after a provider prescribes and the order reaches the pharmacy, “that order can no longer be canceled and is non-refundable.” Canceling otherwise means logging in and turning the subscription off; Oak aims to act within 24 hours, and a refill already paid for and within 48 hours of shipping still goes out. Insurance isn't accepted. FSA and HSA cards are.

Who it's wrong for

Want to pay for one month and see how it goes? Oak doesn't publish that price. The $119 and $185 are twelve-month rates, and shorter plans are priced only at checkout.

Budgeting off the $89 in the banner? No drug page carries that number, and the lowest GLP-1 price on a drug page is $119 on a 12-month plan.

If you want to know who fills and writes your prescription, look elsewhere. Oak names no pharmacy and no medical group.

Skip it if you might change your mind after approval. Once the order reaches the pharmacy it ships and isn't refunded, even if you cancel or try to stop the package with the carrier.

Not for you if you need a firm number at higher doses. The terms let the subscription price change with dosage, and there's no dose table to check.

The American checks

Prescriber licensed in your state
Stated
Pharmacy named
Not named
What you get
Compounded semaglutide and tirzepatide from licensed US compounding pharmacies (“Every prescription filled in the US”), plus branded GLP-1 injector pens and oral Wegovy tablets. Neither 503A nor 503B is stated.
Overseas fulfillment
None disclosed
Support hours
“24x7 Support” on the home page's benefit tiles; Oak's support email and (435) 244-7757 in the footer. No staffed phone hours are given.

What each check means, and what “Not stated” covers, is on how we review.

Questions people ask about Oak

On the record12 sourcing notes: every price with the page it came from, and what the company doesn't publish
  1. Sources: Oak's public site: the home page (Oak's home page), Oak's GLP-1 page, Oak's semaglutide page, Oak's tirzepatide page, Oak's terms of use page, Oak's privacy policy page, Oak's remote health consent page, and an older landing page, Oak's weight loss page, that is live but missing from the menu and the sitemap. The intake at Oak's home page opens on a weight-goal question; nothing was entered.
  2. The prices, verbatim. Semaglutide page: “COMPOUNDED SEMAGLUTIDE From $119/mo On a 12-month plan. Your price is confirmed before checkout. No insurance needed.”, the card “$119 Per month, 12-month plan”, and the FAQ answer “Compounded semaglutide starts at $119/mo on a 12-month plan. Shorter plans are available, and you see your exact price before you pay.” Tirzepatide page: “Compounded tirzepatide starts at $185/mo on a 12-month plan.” and “$185 Per month, 12-month plan”.
  3. The comparison table on the semaglutide page lists “Price at Oak” as “From $119/mo”, “From $185/mo” and, for Wegovy®, “Quoted at checkout”, under the line “Compounded prices shown on 12-month plans.”
  4. Who it's for and how dosing works, from the semaglutide page: “It is generally considered for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes.” “You start on a low dose and step up about every four weeks as tolerated, aiming for the lowest dose that works for you.” “Your provider checks in, adjusts your dose and helps you manage side effects. Message your care team whenever you need to.” The home page: “No appointments, no waiting rooms”.
  5. The home page's top banner reads “Prescription weight loss from $89/mo.” and its GLP-1 tile “from $89/mo”. No drug page, FAQ answer or table carries $89.
  6. The older /weight-loss page still says “Oak's programs start at as little as $190/month or lower!”, prints “Monthly Cost $190/mo” in a comparison table with “Membership Fees None”, and promises “No membership fees, cancel anytime.” Its buttons point to Oak's home page rather than the intake the current pages use. The current drug pages carry none of these figures, and no current page says every dose costs the same.
  7. The membership fee, from the terms of use (“Effective Date: December 30, 2025”): “In the Oak Longevity checkout payment experience, patients are charged a membership fee for a Provider consult (either asynchronous or synchronous), and other value added services made available from time to time by Oak. The portion of the fee that Provider is contracting with Oak to deliver for a consult is contracted at $40 for synchronous (video) professional services visit and $20 for asynchronous professional services.”
  8. Billing and cancellation, from the terms: “most of these prescriptions are configured as a subscription that will renew on a recurring basis.” “Your Subscription fee may change from time to time based on changes in dosage, prescription or form of product. You can cancel at any time by logging into the Site and choosing to cancel your subscription or close your account. Cancellation will take effect on a best-efforts basis, but Oak will aim within 24 hours of action taken. Any refills and orders that are paid and within 48 hours of shipment will be sent and cancellation will take effect after the current shipment.”
  9. Refunds, from the “Refund, Shipping, Cancellation Policy” in the terms: “once a provider has approved and prescribed your treatment and your order has been sent to our pharmacy or fulfillment partner, that order can no longer be canceled and is non-refundable. It will be shipped and delivered and no refund will be issued — even if you cancel your account or subscription after approval, and even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx (or any other carrier) or with the pharmacy or fulfiller.”
  10. The operator's names, all from the same terms page: “Oak Longevity Holdings Corp® TERMS OF USE”, “Leaf Longevity Holdings Corp. DBA Oak Longevity (“OAK”) PROVIDES AN ONLINE PLATFORM”, “Oak Longevity Corp (referred to as “Oak”, “Oak Longevity” “we ”, “us”, or “our”) owns and operates the website Oak's home page”, and a second agreement (“Last updated: December 30, 2025”) issued by “Oaklovesyou LLC”, which mentions an “Oak Pharmacy Network” without naming a member. The footer reads “© 2026 Oak Longevity Holdings Corp.”
  11. Why the licensure row reads yes and the pharmacy row doesn't. Home page tiles: “US licensed providers” over “In every state we ship to”, “Licensed pharmacies” over “Every prescription filled in the US”, and “Licensed in all 50 states”. No pharmacy is named on any page read, and neither 503A nor 503B appears. Support: the home page lists “24x7 Support” among its benefits and gives Oak's support email and (435) 244-7757.
  12. No FDA enforcement action on record: FDA's warning-letter index shows no letter addressed to Oak, Oak Longevity, Leaf Longevity, Oaklovesyou LLC or Oak as of September 2026. The index was searched under each of those names, and the same search returned the letters on file for DirectMeds, Roen Health and Sprout Health. Search FDA's warning letters.

Sources

Oak's own pages

  • Oak's semaglutide pageCompounded semaglutide price
  • Oak's tirzepatide pageCompounded tirzepatide price

FDA

Prices come from the company's own public pages only; the dated quotations are in On the record above.

What Oak sells, priced across the market

The same molecules at every other company we have reviewed, with the range each one falls in.

Across every company

Oak's record is one of the inputs to these pieces, so a correction here moves their numbers too.

Words used above: Compounded, 503A, 503B, Membership, HSA and FSA. All of them are in the glossary.

Check current price →

Partner link. We earn a commission if you start care through it, at no extra cost to you. Who pays us.

Every company we have reviewed is on the reviews index. See who writes these reviews. Your privacy choices and the terms of use apply to this page.